FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,953,000 | +175.0% | 158,042 | +24.1% | 0.00% | +300.0% |
| Q4 2020 | $2,165,000 | +2001.9% | 127,327 | +483.7% | 0.00% | – |
| Q3 2020 | $103,000 | -36.0% | 21,814 | -17.6% | 0.00% | – |
| Q2 2020 | $161,000 | -48.2% | 26,468 | -48.6% | 0.00% | -100.0% |
| Q2 2019 | $311,000 | +182.7% | 51,544 | +334.2% | 0.00% | – |
| Q4 2018 | $110,000 | -45.3% | 11,870 | +77.8% | 0.00% | -100.0% |
| Q2 2017 | $201,000 | -63.3% | 6,677 | -50.5% | 0.00% | -66.7% |
| Q1 2016 | $548,000 | +84.5% | 13,488 | +13.0% | 0.00% | +50.0% |
| Q2 2015 | $297,000 | – | 11,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |